FIELD: biotechnology, molecular biology, microbiology, genetic engineering.
SUBSTANCE: invention relates to a method for preparing an immunogenic polypeptide inducing immune response that represents the protective response against infection with Bacillus anthracis. Proposed immunogenic polypeptide comprises from one to three domains of the full-scale Protective Antigen (PA) from B. anthracis or their variants and at least one of indicated domains represents domain 1 or domain 4 from PA or its variant. These variants of immunogenic polypeptide and full-scale PA are produced as result of expression in E. coli. Also, invention proposes a vector for expression in bacterial cells that comprises nucleic acid encoding abovementioned immunogenic polypeptide. Also, invention the developed method for prophylaxis of infection caused by B. anthracis based on administration of sufficient amount of immunogenic polypeptide. Also, invention proposes a vaccine for prophylaxis of infection caused by B. anthracis that comprises the effective amount of immunogenic polypeptide and a suitable carrier. Invention provides preparing the effective agent used for prophylaxis of infection caused by B. anthracis.
EFFECT: improved preparing method and valuable properties of polypeptide and vaccine.
22 cl, 5 dwg, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
EXPRESSING SYSTEM | 2001 |
|
RU2385348C2 |
DNA-STRUCTURE ENCODING MODIFIED VERSION OF PROTECTIVE ANTIGENE BACILLUS ANTHRACIS | 2015 |
|
RU2622085C2 |
E. COLI STRAIN - PRODUCER OF ISOLATED DOMAIN 1 OF PROTECTIVE BACILLUS ANTHRACIS ANTIGEN IN FORM OF VIRUS-LIKE PARTICLES | 2016 |
|
RU2633508C1 |
ECOLI STRAIN - PRODUCER OF FULL-DIMENSIONAL PROTECTIVE BACILLUS ANTHRACIS ANTIGEN IN FORM OF VIRUS-LIKE PARTICLES | 2016 |
|
RU2633504C1 |
TUBERCULOSIS VACCINE WITH IMPROVED STRENGTH | 2004 |
|
RU2342400C2 |
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY | 1993 |
|
RU2141528C1 |
PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPY SCHEMES BASED ON VACCINES | 2013 |
|
RU2609651C2 |
MUTANT POLYMERASES OF HEPATITIS B VIRUS | 2012 |
|
RU2625021C2 |
OspA CHIMERIC GENES, PROTEINS, AND METHODS FOR THEIR USE | 2011 |
|
RU2636455C2 |
PROPHYLAXIS, TREATMENT AND DIAGNOSTICS OF INFECTION CAUSED BY P.GINGIVALIS BACTERIA | 2009 |
|
RU2535898C2 |
Authors
Dates
2006-02-27—Published
2001-07-06—Filed